FEC approves revised National Biotechnology Policy – Official

The Federal Executive Council (FEC) has approved the revised National Biotechnology Policy 2026, marking a major step forward in Nigeria's approach to leveraging biotechnology for national development. The decision was made during a meeting chaired by President Bola Tinubu in Abuja on Wednesday. This updated policy replaces the 2001 version, which had guided biotechnology efforts in the country for over two decades. The new framework aims to align Nigeria's biotechnology strategies with recent advancements in science and technology, ensuring the nation can better compete globally in key sectors such as agriculture, healthcare, industry, and environmental sustainability. The National Biotechnology Research and Development Agency (NBRDA) has expressed its enthusiasm over the FEC’s endorsement. In a statement released on Friday, Toyin Omozuwa, the agency’s press secretary, highlighted how the revised policy will enable more efficient utilization of biotechnology to drive economic progress and national development. She noted that the policy was approved following discussions at the FEC meeting, which emphasized the need to modernize Nigeria’s biotech strategy in light of rapid scientific and technological changes. The new policy outlines a comprehensive roadmap for enhancing biotechnology research, development, application, and commercialization. It focuses on areas such as precision agriculture, climate-smart technologies, advanced manufacturing, gene editing, and genomics. These initiatives are intended to address pressing national challenges while promoting innovation and attracting foreign investment. According to Ms. Omozuwa, the policy also includes the Nigeria Biotechnology Partnership, which seeks to deepen Nigeria’s engagement with global biotechnology networks through collaborative projects and shared resources. Director-General of NBRDA, Abdullahi Mustapha, praised the FEC’s decision, stating that the revised policy provides essential guidance for strengthening research and facilitating technology transfer and commercialization. He emphasized that the policy will help translate scientific discoveries into tangible benefits for Nigerian society, including improved agricultural productivity, enhanced healthcare delivery, and sustainable industrial practices. Mr. Mustapha also noted that the agency plans to work closely with government bodies, academic institutions, private sector entities, and other stakeholders to implement the policy effectively. The director-general further commended President Tinubu for his leadership in supporting innovation and scientific advancement. He stated that the administration’s recognition of biotechnology as a crucial driver of economic growth underscores its commitment to long-term development. Additionally, he acknowledged the contributions of the Minister of Innovation, Science and Technology, Kingsley Udeh, who has been instrumental in fostering biotechnology initiatives within the country. The revised policy is expected to create a robust environment for biotechnology innovation, enabling Nigeria to capitalize on emerging technologies and global partnerships. With the new framework in place, NBRDA aims to develop cutting-edge technologies and services tailored to meet the nation’s specific needs. The agency is optimistic that this strategic shift will position Nigeria as a leader in biotechnology-driven development, contributing significantly to both economic prosperity and social well-being.